PEOPLE - Closure Medical (US) makes appointment:
This article was originally published in Clinica
Executive Summary
Biomaterial-based medical device company Closure Medical (Raleigh, North Carolina) has elected Daniel Cole as chairman of its board of directors. Mr Cole has been director of the company since July 2003, and has served as senior vice-president and group president of Boston Scientific. He succeeds Ronald Ahrens, who retired last week upon the expiration of his term.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.